Education & Training: Archives


Development of training DVD for Introduction of Pneumococcal Vaccine

Nairobi-Kenya 31 December, 2010

Kenya is the first African country to introduce the new pneumococcal vaccine, PCV10, into their national immunisation programme. The recommended schedule to administer the vaccine is at 6, 10 and 14 weeks, at the same time as the pentavalent vaccine (DTP-HepB/Hib). This pneumococcal vaccine is presented in a liquid form in a two-dose vial without preservative. This implies that an opened vial must be discarded at the end of each immunisation session or after 6 hours from first opening, whichever comes first. An opened vial of PCV10 cannot be stored in the refrigerator for use in subsequent immunisation sessions. This is not in line with the WHO policy on the use of opened multi-dose vials of vaccine in subsequent immunisation sessions. Therefore, specific training on the use and storage of this new two-dose pneumococcal vaccine was felt needed.

As part of the training materials for the introduction of this new pneumococcal vaccine, a training DVD was developed intended for health care workers. A training DVD will ensure that the same training messages are received by all, minimizing the risk of the messages being diluted. The DVD will be a tool to deliver and reinforce standard training messages related to new vaccines’ delivery. It will provide a medium to deliver standard training to a large number of people. The target audience for this DVD are the vaccinators, i.e. health care workers giving the vaccines, as well as the immunisation staff at district and national level (i.e. supervisors of the health care workers). The DVD will also be used in pre-service training for nurses.

Watch the DVD.

Southern Africa Vaccinology Course

Cape Town-South Africa 8 November, 2010 to 12 November, 2010

NESI has been active in building capacity in immunisation for the Southern African sub-region since 2005 through annual vaccinology courses with the University of Cape Town (UCT), South Africa, as local organiser. The sixth Southern African vaccinology course was organised in Cape Town, South Africa, from 8 to 12 November 2010, and was hosted by the Vaccine for Africa Initiative (VACFA), based at UCT’s Institute for Infectious Diseases and Molecular Medicine.

The main objective of the course was to build sustainable research capacity to develop vaccines and/or conduct quality standard phase 1 to phase 4 vaccine clinical trials. The course also aimed to provide participants with the necessary expertise to support public vaccination programmes.

Participants ranged from EPI managers, medical doctors, nurses, public health specialists, academics and scientists working in the field of vaccinology.

NESI gave three lectures: Hepatitis A & B vaccines; HPV vaccines; and Immunisation schedules.

Workshop to develop Vaccinology Modules

Pretoria-South Africa 13 September, 2010 to 16 September, 2010

In April 2009, a first workshop was organized to develop generic training materials and handouts for vaccinology courses. During this meeting, a list of 40 vaccinology modules was developed and two key facilitators for each module were identified. In September 2010, a follow up workshop to further develop and harmonise the vaccinology modules was organised in Pretoria, South Africa, by the South African Vaccines and Immunisation Centre (SAVIC)/University of Limpopo and the Network for Education and Support in Immunisation (NESI)/University of Antwerp, in collaboration with WHO/AFRO and the University of Pretoria. The workshop was attended by 14 participants from WHO/AFRO (3); SAVIC/University of Limpopo (4); University of Pretoria (1); University Cheikh Anta Diop in Dakar, Senegal (1); School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (1); and NESI/University of Antwerp (4).

Specific objectives of the workshop included:

  • Further develop/harmonise the vaccinology modules using the reference format
  • Discussion of process of review and validation of the vaccinology modules
  • Discussion on distribution of the vaccinology modules

At the end of the workshop, a revised/updated list of the modules was developed, as well as stock taking of the status of each module. The list of facilitators and reviewers was updated and a timeline was set for completion of the modules. The overall coordination of the modules will be handled by NESI. Modules should be finalised by mid 2011, followed by a peer technical review meeting.

Francophone Regional Vaccinology Course

Cotonou-Benin 23 August, 2010 to 28 August, 2010

The second regional vaccinology course for francophone countries was organised by WHO/AFRO in collaboration with the Ministry of Health of Benin, UNICEF, USAID and NESI, from 23 to 28 august in Cotonou, Benin.

The course was attended by 52 participants from 18 countries: Benin (3), Burundi (1), Cameroun (3), Comoros (3), Congo (3), Cote d’Ivoire (4), DRC (4), Gabon (2), Guinea (3), Equatorial Guinea (2), Mali (2), Madagascar (3), Mauritania (3), Niger (4), RCA (3),  Senegal (3), Chad (3), and Togo (3). Twenty-seven participants were from the respective Ministries of Health, 13 participants were academics and 12 were WHO/UNICEF focal points and related staff.

Facilitators of the course included: international vaccinology experts (2); WHO (7); University Cheikh Anta Diop, Dakar, Senegal (1); NESI (2). NESI gave lectures on the following topics: Epidemiology; HPV vaccines; Adolescent vaccination; Introduction of new vaccines; Hepatitis B and Hib vaccines; Clinical trials. NESI also co-facilitated the group work and chaired several sessions.

The course was highly appreciated as shown by the daily and summative evaluations. The overall evaluation related to the content of the course was 93%.

Introduction of New Vaccines-Experience Exchange Meeting

Pretoria-South Africa 28 July, 2010 to 30 July, 2010

The Experience Exchange Meeting on the introduction of new vaccines took place in Pretoria, South Africa, from 28 to 30 July 2010, and was organised by SAVIC/University of Limpopo Medunsa Campus in collaboration with the University of Pretoria and the Network for Education and Support in Immunisation (NESI)/University of Antwerpen. This meeting was convened at a time when countries are augmenting their strategies to reach UN Millennium Development Goals. Introduction and widespread use of new or improved vaccines (such as rotavirus and pneumococcal vaccines) can contribute greatly to achieving the UN MDG Target 4 of reducing global childhood mortality by two-thirds by 2015.

The primary objectives included:

  1. An update on GIVS and mortality reduction goals in the framework of the UN MDGs;
  2. Discussing recent advances in new vaccines and their use;
  3. Exchanging lessons learned and best practices regarding new vaccines introduction;
  4. Discussing cold chain and logistics for preparation of new vaccines introduction;
  5. Discussing integrated management of immunization.

The secondary objectives were to

  1. Promote discussion on opportunities and challenges faced by the African continent in introducing new vaccines;
  2. Continue strengthening immunization programs through partnerships between various stakeholders: international health agencies, public, private, academic and NGO’s.

The meeting was attended by 59 participants from eleven countries being health officials from the South African Department of Health, EPI managers from 7 sub-saharan African countries, WHO, vaccination experts and academics from Africa and Europe.

The meeting was of great value to the delegates and the lessons learnt would be useful in the future as more African countries embark of the journey of introducing new vaccines and ensuring that every child in every city and village on the continent is protected from vaccine preventable diseases.The key advocacy message from South Africa is that EPI-SA is committing to reaching every child with quality modern vaccines, ensuring protection from vaccine-preventable diseases.

Advanced Course on Vaccinology in Asia-Pacific Region

Seoul-South Korea 10 May, 2010 to 15 May, 2010

This annual vaccinology course was organised for the 10th time by the International Vaccine Institute (IVI), in collaboration with the London School of Hygiene and Tropical Medicine, from 10 to 15 May in Seoul, South Korea. The course is intended for scientists and decision-makers involved in vaccine development, in the implementation of new vaccination strategies or in policy decisions related to the introduction of new vaccines in public health programmes. It is relevant for both the public and private sectors. The course was attended by 82 participants from 22 countries: Bangladesh (1), Korea (16), China (7), India (8), Indonesia (14), Turkey (5), Thailand (2), Taiwan (2), Philippines (4), USA (2), Gabon (1), Bhutan (4), Singapore (1), Sudan (1), Sri Lanka (1), Pakistan (2), Myanmar (2), Niger (4), Vietnam (1), Ghana (1), Nepal (2), Netherlands (1).

NESI was invited to be part of the faculty and lecture on ‘Integration of immunisation and other health interventions in the health service context’.

Troped Advanced Vaccinology Course

Rixensart-Belgium 10 January, 2010 to 15 January, 2010

The TropEd advanced vaccinology course was organised by the Institute of Tropical Medicine and International Health, Berlin, GSK Biologicals and NESI/UA, from 10 to 15 January 2010 in Rixensart, Belgium. There was a collaboration with 3 Universities of South Africa (Cape Town,  Pretoria and Limpopo) and the University Cheikh Anta Diop (Senegal). The course is an accredited module (2 ECTS credit points) in the TropEd Masters Programme in International Health. TropEd is a network of institutions for higher education in International Health (including 33 European institutions and 7 non-European institutions). Forty participants from developing and industrialised countries attended the course: Ethiopia (2), Eritrea (1), Columbia (1), Sudan (3), Nigeria (3), Nepal (1), Kenya (3), India (1), Taiwan (1), Indonesia (1), Belarus (1), Belgium (2), Germany (13), the Netherlands (3), Canada (1), Panama (1), Spain (1), Switzerland (1).

Teaching methods include seminar-style and interactive lectures, group work on specific diseases, and a visit to a vaccine production site. Students had to write a 5-page assignment on a self-defined topic relevant to vaccines and immunisation, which was evaluated by the course organisers.

NESI staff gave lectures on the following topics: mission and achievements of NESI (presented during the opening session); HPV vaccines; adolescent vaccination; decision-making process for new vaccine introduction; malaria global burden and interventions. NESI also co-facilitated the group work and chaired several sessions.


“SAVIC-Gauteng 2009 EPI symposium” – Introduction of new vaccines into national immunisation programmes

Johannesburg-South Africa 2 February, 2009 to 3 February, 2009

The SAVIC-Gauteng 2009 EPI symposium was organised by SAVIC/University of Limpopo and Gauteng Province Department of Health, in partnership with the South African national Department of Health, WHO/AFRO, NESI/UA and the University of Pretoria. The symposium was approved for accreditation.
The official opening address was given by Dr. Stella Anyangwe from WHO country office. The opening function was also attended by the Representative of the Flemish Government in South Africa.

The symposium was attended by 103 participants from:

  • WHO, South African National Department of Health, and Provincial Departments of Health: Mpumalanga, North West, Gauteng, Western Cape and Limpopo Provinces.
  • DENOSA (Democratic Nursing Organisation of South Africa)
  • Academia: Tshwane University of Technology, University of Johannesburg, University of Pretoria, University of Witwatersrand, University of Limpopo, National Institute for Communicable Diseases and NESI/University of Antwerp.
  • The vaccine industry: Biovac Institute, GSK, MSD, Sanofi Pasteur and Wyeth SA.

The objective of the meeting was to discuss the introduction of new vaccines into national immunisation programmes, as South Africa recently took the decision to introduce pneumococcal and rotavirus vaccines and a combination vaccine (pentavalent) including IPV.
NESI provided technical and financial support for the symposium. Prof. Meheus gave a presentation on ‘New vaccine introduction and programmatic implications’. Dr. Dochez presented on ‘HPV vaccines’. The new EPI schedule for South Africa was presented by the EPI manager, Dr. Johan Van Den Heever, and will become operational in April 2009. The national advisory group of experts also supports introduction of HPV vaccine but the policy decision has not yet been taken.


Vaccinology Symposium

Hermanus, Cape Town-South Africa 26 October, 2008 to 28 October, 2008

The meeting in Hermanus was the fifth national vaccinology symposium of South Africa. The symposium was attended by experts from the major universities, the national and provincial departments of health, and the private sector. The symposium was organised by Prof. Barry Schoub from the National Institute of Communicable diseases/National Health Laboratory Service, and linked with Witwatersrand University in Johannesburg. The meeting aimed to foster national (South African) expertise teams in vaccinology, an objective in line with NESI objectives and activities. South Africa being the only sub-Saharan country with a significant private sector, the public/private sector collaboration and schedule harmonisation were interesting issues for discussion. Prof. André Meheus was invited guest speaker and presented on ‘Introduction of new vaccines: public health and policy decisions’ and on ‘Adolescent vaccination’. Both topics were of great relevance as South Africa recently took the decision to introduce pneumococcal and rotavirus vaccines and a combination vaccine (pentavalent) including IPV. The national advisory group of experts also supports introduction of HPV vaccine but here the policy decision has not yet been taken.  The topic on adolescent vaccination was of great interest related to potential HPV vaccine introduction, the need for booster doses and catch-up vaccinations for young adolescents.

Second Regional Vaccinology Course for Francophone countries

Ouidah-Benin 4 October, 2008 to 11 October, 2008

Following a successful first workshop in Douala in 2007, the second Francophone regional vaccinology course was organised by WHO/AFRO and the Ministry of Health of Benin, in collaboration with UNICEF, NESI and the University Cheikh Anta Djop (Dakar, Senegal), from 4 to 11 October 2008. The purpose of this vaccinology course was to build capacity of immunisation key players in countries of the AFRO Region in scientific and public health aspects of vaccines and vaccination programmes.

The course aimed to contribute to the establishment of competent national immunisation technical advisory groups (NITAGs), capable of preparing evidence-based recommendations to Ministries of Health on the introduction of under-utilised and new vaccines, such as Hepatitis B, Hib, conjugate pneumococcal and meningococcal vaccines, rotavirus vaccines and HPV vaccines. In the future, these technical advisory groups may also consider vaccines that are in the pipeline, such as malaria, TB and HIV vaccines. As countries take up the challenge of deciding which vaccines to introduce, WHO/AFRO and partners want to ensure that these technical advisory groups have all the available information at their disposal to make informed, evidence-based decisions.

Participants included professors/academics/researchers (13), EPI managers (17) and WHO/UNICEF staff members and EPI focal points (11). The course was attended by 41 participants of the following countries: Benin, Burkina Faso, Burundi, Cameroon, Côte d’Ivoire, Guinée, Madagascar, Mali, Niger, RDC, Rwanda, Senegal and Togo. Facilitators were from WHO/AFRO and Inter-country teams (5), WHO/HQ (2), NESI (3), WHO/Benin (4), UNICEF/Benin (1), University of Bamako (1) and PATH MVI (1).

The actual vaccinology course was preceded by a two-day Training of Trainers workshop, to enable the facilitators to peer review course content and group work. Teaching methods during the course included: individual pre-reading, lectures and short presentations using interactive media, group work, discussions in plenary and group sessions, case studies and role playing. Discussions and requests for clarifications were held after each set of complimentary presentations.

The overall evaluation of the course was very positive: all topics were rated above 70%, and 79% of all the topics were rated between 80 and 90%. Lectures which were most appreciated included: basic scientific aspects of vaccine development, vaccine terminology, immunology, clinical trials, ethical aspects, and the different presentations on new vaccines.

Last updated: 20 July, 2017 - 10:10